M Heim

Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006.

S Seeber, D. Strumberg, S. Seeber, 2003, International journal of clinical pharmacology and therapeutics.